Adherence and safety of regorafenib for patients with metastatic colorectal cancer: observational real-life study.
about
Incidence and risk of regorafenib-induced hepatotoxicity.Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib.Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice.Evolution of regorafenib from bench to bedside in colorectal cancer: Is it an attractive option or merely a "me too" drug?
P2860
Adherence and safety of regorafenib for patients with metastatic colorectal cancer: observational real-life study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Adherence and safety of regora ...... observational real-life study.
@en
type
label
Adherence and safety of regora ...... observational real-life study.
@en
prefLabel
Adherence and safety of regora ...... observational real-life study.
@en
P2093
P2860
P356
P1433
P1476
Adherence and safety of regora ...... observational real-life study
@en
P2093
Anna Nappi
Antonella Prudente
Bruno Vincenzi
Clementina Savastano
Francesca Andreozzi
Gregorio Cennamo
Maria Biglietto
Patrizia Iodice
Salvatore Del Prete
P2860
P304
P356
10.2217/FON-2016-0421
P407
P577
2016-10-26T00:00:00Z